What the panel ordered
Petition for Removal granted; WCJ's Findings of Fact affirmed except Findings 2 and 3 rescinded and replaced; parties must continue using IMEs pursuant to the ADR agreement; matter returned to trial level for further proceedings.
Petition for Removal granted by the Appeals Board after reconsideration of the WCJ's Findings of Fact dated April 21, 2022, which included interlocutory and threshold issues.
What was disputed, and how it came out
Each issue the panel decided, with the reasoning it gave. An outcome is what this panel did on this record — not a rule, and not a prediction.
The Appeals Board found that the preponderance of evidence supports continuing the use of IMEs as mandated by the ADR agreement, rescinding the WCJ's contrary findings and rejecting the argument that it would be unjust to enforce the ADR provisions regarding IMEs.
From the decision · page 9In this matter, it is true that applicant continued to conduct discovery with his IME after the termination of the ADR agreement. (Exhibit H, Invoice, May 15, 2021; Exhibit I, Report of Eduardo Lin, July 14, 2021; Exhibit S, Medical Cover Letter, July 13, 2021, Exhibit T, Notice of Deposition, April 26, 2021.) [...] In light of the overall record as described above, we are persuaded that the preponderance of evidence establishes that the parties in this case must continue using IMEs as mandated by the ADR agreement. We will amend the Findings of Fact dated April 21, 2022 to rescind the WCJ's findings that that defendant waived the argument that the IME process described in the ADR agreement controls the medical-legal process herein, and that special circumstances exist that render it unjust to enforce the provisions of the ADR contract regarding the usage of IMEs. We will replace those findings with our findings to the contrary, and we will add our own finding that resolves the issue presented at trial, i.e., the parties shall continue using IMEs pursuant to the ADR agreement.